Phenylethylamine for Health & Longevity - Quick Reference Sheet

Phenylethylamine for Health & Longevity

Created on 06/26/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

A natural brain molecule sold cheaply as a supplement for a quick, short-lived lift in focus and mood. Broken down almost instantly, so most of a swallowed dose is gone before it acts. Effects are mild, brief, and vary widely; the clearest finding is a safety one — never combine it with breakdown-blocking drugs. (Full Review)

Protocol

Dose
100–500 mg
Oral, per occasion, often on an empty stomach; taken acutely (as needed), not on a fixed daily schedule
Timing
Early in the day
Morning or early afternoon preferred to avoid sleep disruption; effects felt within minutes and fade quickly
Dosing pattern
Single acute doses
Short half-life means discrete single doses for an acute effect, not steady-state dosing; "splitting" means repeating an acute dose
Time to effect
Onset
Within minutes
Mood lift and focus, when felt, begin within minutes of dosing
Duration
~30–60 minutes
Effects typically fade within roughly 30–60 minutes due to rapid breakdown
Half-life
≈5–10 minutes
Very short unaided; the central practical constraint behind single acute dosing

Benefits

Contraindications
  • MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid, selegiline, rasagiline, linezolid)
  • Uncontrolled hypertension
  • Significant arrhythmia
  • Recent cardiac events (e.g., recent MI <90 days)
  • Pheochromocytoma
  • Bipolar disorder
  • Psychotic disorders
  • Pregnancy or breastfeeding
Key Interactions
  • Other stimulants (amphetamine/methylphenidate, pseudoephedrine, phenylephrine, caffeine, pre-workout products)
  • Serotonergic and noradrenergic antidepressants (SSRIs, SNRIs such as venlafaxine, bupropion)
  • Antihypertensive medications
  • MAO-inhibiting and additive stimulant supplements (high-dose green tea/EGCG, Rhodiola rosea, harmala extracts, synephrine, yohimbine, L-tyrosine, phenethylamine-class amines)

Risk & Side Effects

  • High: Hypertensive reaction when combined with MAO inhibitors
  • Medium: Sympathomimetic / stimulant effects
  • Low: Sleep disruption; mood destabilization in susceptible individuals
  • Speculative: Cardiovascular strain with chronic high-dose use; tolerance and dependence potential

Monitoring

Marker Target Why
Resting blood pressure <120/80 mmHg Detects PEA's pressor (blood-pressure-raising) effect
Resting heart rate 50–70 bpm Flags stimulant-driven increases in heart rate
Fasting glucose / insulin sensitivity Fasting glucose 70–85 mg/dL Context marker, as trace amines may influence insulin signaling

Cadence: Re-check blood pressure and heart rate after the first few uses and whenever the dose is increased; for anyone with cardiovascular risk factors, periodic checks every few months during regular use.

Qualitative Assessment

  • Noticeable but comfortable lift in focus, motivation, or mood within minutes of dosing
  • Absence of jitteriness, anxiety, palpitations, or headache
  • No disruption of sleep when used earlier in the day
  • Stable, controlled blood pressure and heart rate over time